InspireMD director awarded 88,053 restricted shares
InspireMD, Inc. director receives restricted stock grant.
Rhea-AI Filing Summary
InspireMD, Inc. director receives restricted stock grant. Director Gary S. Roubin reported an award of 88,053 shares of InspireMD common stock on January 14, 2026. The shares were acquired at a stated price of $0 per share as a stock award, increasing his beneficial ownership to 744,478 common shares held directly. The 88,053 shares are restricted stock that will vest on January 14, 2027, provided he continues to serve through that one-year grant anniversary date.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 88,053 | $0.00 | $0.00 |
Footnotes (1)
- F1. These shares of common stock represent shares of restricted stock that shall vest on January 14, 2027 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service.
FAQ
What insider transaction did InspireMD (NSPR) report for Gary S. Roubin?
Director Gary S. Roubin reported acquiring 88,053 shares of InspireMD common stock on January 14, 2026 as a stock award coded as an acquisition.
What is Gary S. Roubin’s relationship to InspireMD (NSPR)?
Gary S. Roubin is reported as a director of InspireMD, Inc. and is not listed as an officer or 10% owner in this filing.
Is the reported InspireMD (NSPR) insider transaction a sale or a grant?
The Form 4 shows an acquisition (transaction code A) of 88,053 common shares at $0, indicating a restricted stock grant, not a sale.
AI-generated analysis. How Rhea-AI works. Not financial advice.